Clinical trial
Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological…
NCT00125775 · Chinese University of Hong Kong, Other · Completed
Key facts
| NCT number | NCT00125775 |
|---|---|
| Title | Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients? |
| Official title | Phase 4 Study of Recombinant Hepatitis B Vaccine in Peritoneal Dialysis Subjects |
| Lead sponsor | Chinese University of Hong Kong, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Peritoneal Dialysis, Renal Disease, End-Stage |
| Intervention type | Biological |
| Interventions | Engerix-B |
| Enrollment | 130 |
| Start date | May 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Aug 2, 2005 |
| Last update posted | Jan 7, 2010 |
| Countries | Hong Kong |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: